Mastering Your Weekly Routine: Where Do You Put Wegovy Shot and How to Inject Safely

Last reviewed: June 26, 2026

Last updated: June 26, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Weekly semaglutide injections require knowledge of safe injection sites and rotation patterns to maximize therapeutic benefit and minimize tissue complications. Clinical data shows that rotating injection locations reduces the risk of localized fat buildup by up to 40 percent. This guide covers everything you need to know about administering your weekly GLP-1 therapy safely at home.

Understanding the Correct Injection Sites for Semaglutide

Semaglutide injections are designed for subcutaneous delivery, meaning the medication enters fatty tissue just beneath the skin. The FDA-approved injection sites include the abdomen, thigh, and upper arm—three areas with sufficient subcutaneous fat to allow proper medication absorption. Each site offers practical advantages depending on your comfort level, visibility, and daily routine.

The abdomen is the most commonly recommended location because it provides excellent visibility for self-injection and consistent absorption rates. Choose an area at least two inches away from your belly button to avoid sensitive tissue near internal organs. Many patients find morning injections into the abdominal area easiest to integrate into their weekly routine, as they can do it at home before breakfast.

Rotating Injection Sites to Prevent Lipohypertrophy

Lipohypertrophy—abnormal fat buildup at repeated injection sites—occurs when the same location receives injections week after week without rotation. This condition can alter medication absorption rates and create uncomfortable lumps or thickened skin patches. PlexusDx recommends establishing a rotation schedule across your three approved sites to distribute the weekly dose evenly over time.

A practical rotation approach divides each approved site into smaller sections and cycles through them systematically. For example, rotate between the right abdomen, left abdomen, right thigh, left thigh, right upper arm, and left upper arm across consecutive weeks. This six-week cycle ensures no single area receives more than one injection per month, significantly reducing lipohypertrophy risk while maintaining consistent drug absorption.

Step-by-Step Safe Injection Technique for Weekly Doses

Begin by gathering your semaglutide pen, alcohol wipe, and a sharps disposal container in a clean, well-lit area. Check that your medication has reached room temperature and inspect the pen for any discoloration or particles—if either is present, do not use it. Wash your hands thoroughly with soap and water, then clean your chosen injection site with an alcohol wipe and allow it to air dry completely.

Hold the skin around your injection site between your thumb and fingers to create a slight fold, which helps the needle enter at the proper depth. Insert the needle at a 90-degree angle in a quick, confident motion—hesitation can increase discomfort. Depress the injection button slowly and hold for three seconds to ensure the full dose delivers, then withdraw the needle and apply gentle pressure with a clean tissue for several seconds if bleeding occurs.

Why PlexusDx Compounded Semaglutide Offers Consistent Weekly Administration

PlexusDx partners with licensed 503A compounding pharmacies to provide semaglutide injections formulated specifically for weekly subcutaneous administration. Unlike oral formulations, injected semaglutide bypasses the digestive system entirely, delivering reliable bioavailability week after week. This consistency helps your body maintain stable GLP-1 receptor activation, supporting sustained weight management results.

PlexusDx compounded semaglutide injections start at $149 per month with no insurance required, HSA/FSA eligibility, and access across all 50 states. Each patient receives detailed injection coaching and rotation guidance to ensure safe, effective weekly therapy. For patients interested in understanding their individual peptide pathway response, PlexusDx offers the Precision Peptide Genetic Test—a $99 add-on after your first treatment month that maps 14 pathways and 49 peptides to personalize your therapy approach.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide in the same spot every week?

No—repeating the same injection site weekly significantly increases lipohypertrophy risk, which causes uncomfortable fat buildup and can reduce medication absorption. PlexusDx recommends rotating through approved sites (abdomen, thigh, upper arm) following a systematic schedule, such as a six-week cycle using different sections.

What is lipohypertrophy and why does it matter for GLP-1 therapy?

Lipohypertrophy is abnormal thickening and fat accumulation at repeated injection sites, caused by chronic needle trauma and local inflammation. It can alter how your body absorbs semaglutide, potentially reducing medication effectiveness. Clinical research shows site rotation reduces lipohypertrophy incidence by approximately 40 percent.

How much does PlexusDx compounded semaglutide injection cost?

PlexusDx compounded semaglutide injections from licensed 503A pharmacies start at $149 per month on the most affordable commitment tier. Your dose may need to go up during therapy, but your price won't change. No insurance is required, and the medication is HSA/FSA eligible.

Is it safe to self-inject semaglutide at home?

Yes—subcutaneous semaglutide injection is designed for home self-administration and is safe when proper technique, site rotation, and sterile handling are followed. PlexusDx provides detailed injection coaching with each shipment to ensure you feel confident administering your weekly dose independently.

Can PlexusDx genetic testing help me optimize my semaglutide therapy?

Yes—the PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 150+ genetic insights across 14 peptide pathways, including GLP1R rs6923761 and GIPR rs1800437 variants that influence individual semaglutide response. This personalization helps optimize your treatment strategy.

Related Reading

• Wegovy Shot
• Ro Wegovy
• Mochi Wegovy
• Noom Wegovy

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.